Thank you for submitting your manuscript for consideration by The EMBO Journal. I have now received the reports from three expert reviewers, which you will find copied below. As you will see, all referees find your results interesting and potentially important, yet raise a number of specific points needing to be addressed. We shall therefore be happy to consider a revised version of the manuscript further for publication, pending adequate revision of these referee concerns. In this respect, it will be particularly important to analyze UPF1 localization by ChIP during the cell cycle (referee 2 point 1), and to test whether fragile telomeres arise preferentially at leading telomeres (referee 2 point 2). Among the more specific technical points, an important issue shared by all referees is the lack of statistical analysis throughout the study. Finally, both reviewers 1 and 2 raise concerns specifically about the data in Figure 7 ; while one of these referees feels these data could simply be left out, I have to admit that I am reluctant to follow this suggestion, and would in the interest of the conclusiveness of the paper much prefer if these problems could be decisively clarified in one way or another during revision.
I should add that it is EMBO Journal policy to allow only a single round of revision, and acceptance of your manuscript will therefore depend on the completeness of your responses in this revised version. We generally allow three months as standard revision time, and it is our policy that competing manuscripts published during this period will have no negative impact on our final assessment of your revised study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html Please don't hesitate to contact me should you have any further question regarding this decision or your revision! I look forward to your revision.
Yours sincerely, Editor
The EMBO Journal _____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication In this manuscript Chawla et al suggest a role for UPF1 in telomere leading strand replication. The authors show that low levels of UPF1 bind to telomeres specifically in a telomere length dependent manner. ATR appeared to be involved, since ATR targeting resulted in a decrease of UPF1 interaction with telomeres. Next the authors carefully analyze the interaction between UPF1 and hTERT and find that UPF1 binds to hTERT in a DNA independent way. This interaction seemed dependent on ATR kinase activity. Further analysis revealed that UPF1 interacted with TPP1 via its OB-fold. UPF1 depletion and expression of a UPF allele compromised for ATPase function led to the accumulation of telomere free ends and fragmented telomeres. Telomere loss was specific for the telomeres replicated by leading strand synthesis, suggesting that active UPF1 is required to coordinate leading strand telomere synthesis. TIF analysis suggested that UPF1 depletion leads to recognition of telomeres as lesions. Since RPA colocalized, the single stranded DNA response machinery appears to play a role there, which was confirmed by in gel hybridization approaches. In summary this manuscript deals with an important question, is experimentally sound and interesting to a wide readership. EMBOJ is a very appropriate choice for this paper and the findings should be published there after minor revisions (see below).
A few questions should be addressed prior to publication: I am surprised the authors do not observe cell cycle changes upon ATR depletion. Usually this makes cells very unhappy and results in delayed S phase progression. Why is there more TRF1 binding to telomeres in the inactive-hTERT-HA expressing cells? Looking at the error bars this appears to be significant. The authors specifically state that UPF1 binds to active hTERT. This however is not clear from Figure 2 , so this statement should be weakened. Why was no leading strand telomere phenotype observed in the TPP1 knockout? The single stranded telomere detection approaches in Figure 7 are experimentally weak and could simply be left out.
Referee #2 (Remarks to the Author):
In this manuscript, Chawla et al. report interesting findings that UPF1 physically interacts with TPP1 and telomerase but not TRF2 or Rap1. They show that UPF1 localizes at telomeres, although weakly, in an ATR-dependent manner. The ATPase activity of UPF1 seems to be required for efficient replication of leading strand telomere DNA. They also reported that UPF1 depletion leads to accumulation of telomeric ssDNA and increase of RPA and gamma-H2AX foci at telomeres. Overall, these are important and novel findings, but they are largely descriptive and the findings of UPF1 interacting with TPP1 and telomerase does not necessarily support the role of UPF1 in leading strand replication. The authors need to strengthen at least one part of the story, especially UPF1's function in telomere replication and provide more evidence to sufficiently support the author's conclusions. The following concerns need to be addressed before considering for publication:
1. The ChIP signal of UPF1 localization at telomeres is quite weak. Statistical analysis is needed to show the significance of ChIP, especially when there is only two fold difference and the error bars are big. More importantly, as the authors themselves suggested, the low signal may be due to transient association of UPF1 to telomeres, most likely in S phase. Since one of the major conclusions of this manuscript is that UPF1 is important for leading strand replication of telomere DNA, one would speculate that UPF1 should have stronger association with telomeres during the S phase. This conclusion would be strengthened if the authors show the UPF1 ChIP during the cell cycle.
2. The authors demonstrate nicely that shUPF1 increases telomere free ends and fragile telomeres in Fig. 5 and show that the increase of TFE occurs mainly at the leading telomeres. However, TFE could result from other defects in telomere DNA metabolism and not necessarily from replication fork collapse. While the authors claims that "in UPF1-depleted cells, stalling of the replication fork on leading-strand telomeres remains the most important defect leading to the observed accumulation of FTs" (page 18), it needs to be shown that FTs also occur preferentially at leading telomeres.
3. In Fig. 7 , the authors included ss signals from wells for quantitation. It is unclear why the authors included them. Since the control shEV also contain strong signals in wells, which it shouldn't, how do the authors know that the well signals are not from non-specific binding of probe to DNA? Many publications from various groups have shown that most if not all human telomere DNA is able to migrate into agarose gel and the signals from wells are very minimal. This raises question about whether the technique worked properly in the author's hands. In addition, statistical analysis should be conducted for fig. 7C . Referee #3 (Remarks to the Author):
UPF1 plays a conserved role across species in cytoplasmic RNA quality control. In mammals, critical components of the NMD machinery, namely SMG6 (hEST1A), SMG1, and UPF1 also serve important nuclear functions in telomeric RNA (TERRA) transcription and in telomere protection. Despite intriguing linkages between NMD and telomere regulation, the mechanistic similarities between these processes was not well understood. Moreover, although UPF1 was known to bind telomeres and its depletion led to genome instability, its precise role(s) in telomere and genome instability were unclear. This manuscript presents a significant advance in the field that reveals an ATR-mediated stimulation of UPF1 association with telomeric heterochromatin, in a manner akin to the stimulation of NMD via UPF1 phosphorylation by SMG1. Several lines of evidence are provided to support this conclusion, including the ATR-dependent stimulation of UPF1-telomere and UPF1-telomerase interactions, and the essential role of UPF1 to ensure telomere integrity, efficient leading strand telomere DNA replication, and to prevent the appearance of gamma-H2AX and ssDNA at telomeres. These data lead to a model whereby ATR-dependent stimulation of UPF1 (via its ATPase activity) promotes recruitment of telomerase and also promotes leading strand telomere DNA replication via stabilization of replication forks. These data will be of broad interest to those interested in RNA and DNA surveillance, as it provide a new mechanistic link between how the DNA damage response (via SMG1 or ATR) promotes UPF1 association with, and regulation of, its respective partners. The manuscript is thoughtfully written and the data supports the conclusions. There are a few improvements that could be incorporated, as suggested below.
1. The impact of caffeine on the association of UPF1 with telomerase activity is striking. Nonetheless, the authors should include an internal control for the telomere repeat addition protocol (TRAP), which will confirm equivalent PCR amplification efficiency. In Figures 2B and 3B , an extract titration (as in Fig. 3A ) of the relevant IP samples will further establish the lysates are measured within the linear range for TRAP, and would underscore the relative enrichment of test samples relative to the "beads only" control. Addition of an irrelevant antibody in the IP tests may also be helpful as an additional negative control, since the background binding might be even less than "beads only".
2. The number of telomeric DNA repeats in cell lines that overexpress hTERT is greater than EV or hTERT-HA controls, and it is unclear whether the UPF1-telomere association is enriched when normalized to total telomeric DNA content. For the statement that "telomere elongation promotes UPF1 binding to telomeres" (p. 7/8), please clarify whether the data supports a simple enrichment due to the presence of more substrate, or a synergistic recruitment of UPF1 even after normalization to total telomeric DNA content.
3. The data in Figure 5 illustrates the biological significance of UPF1 ATPase activity in telomere replication and integrity in vivo, and the statistical analysis underscores these compelling effects. Please also include statistical analysis (p-values) for the data in Figures 1D, 3D , 6B and 7B, e.g. two-tailed student's t-test or one-way ANOVA. Wherever percentage values are mentioned in the text, please include S.E. or STD DEV and p-values for the relevant sample comparison. In Figure 4 , although one representative experiment is shown, it would be helpful to mention how many times the experiments were replicated for each figure panel. Please include a section in the Methods to clarify how the ChIP data was normalized, and statistical methods to explain how p-values were calculated (including the Mann-Whitney tests in Figure 5 ).
4. In vivo, the association of UPF1 with telomeres was reduced in cells expressing hTERT-HA (Fig.  1D ). This result is interesting and was clearly statistically significant, and raises two possibilities that should be addressed in the text or experimentally. The first question is whether the relative telomeric association of hTERT-HA is reduced relative to hTERT; the second question relates to the relative association of UPF1 with untagged hTERT versus hTERT-HA (e.g. only the UPF1-hTERT-HA interaction is tested in Fig. 2C ).
5. Minor grammatical editing and clarification would be beneficial, for example some terms such as "associated to only beads samples", "knocked-out", "properly running in the gel" and "wellassociated" could be replaced with more precise terminology. In some cases, the singular tense might be more appropriate (e.g. "dysfunctions", "settings"). In Methods, "%" should be followed by "w/v" or "v/v". The Discussion is thoughtful and provocative, however it could be shortened without compromising on content or clarity.
6. Suppl. Fig. 1B . Please indicate clearly which panels were probed with each antibody. If anti-HA was employed in the third panel, please explain the signal in the cell line expressing untagged hTERT (i.e. which might occur if the blot was probed first with anti-hTERT antibody). We would like to thank you for giving us the possibility to submit a revised version of our manuscript entitled 'Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication' (Manuscript EMBOJ-2011-77691) for publication in The EMBO Journal.
As thoroughly explained in the following 'point-by-point response', we have now addressed the concerns of the three Referees experimentally or in the text. In particular, we would like to emphasize that we were able to demonstrate that UPF1 is present at telomeres during S phase and that, in UPF1-depleted HeLa cells, not only telomere-free ends but also fragile telomeres accumulate on chromatids generated by leading strand-replication.
Due to a substantial amount of new data, our revised manuscript now comprises 8 main figures (originally 7) and 6 supplementary figures (as before). In addition, a part of the 'Materials and Methods' section is now shown as 'Supplementary Information'.
We truly hope that the current version of our manuscript is suitable for publication in The EMBO Journal and we thank you very much for your kind help. In our hands, HeLa cells transfected with the utilized anti-ATR shRNA plasmids do not suffer from any evident cell cycle delay for the first 4 days of cell culturing. Consistent with the Referee's comment, further culturing of these cells leads to aberrant S phase progression and, eventually, to cell death. We deliberately chose to perform our ChIP experiments at day 4 in order to achieve the highest possible levels of ATR depletion without affecting cell cycle progression.
Why is there more TRF1 binding to telomeres in the inactive-hTERT-HA expressing cells? Looking at the error bars this appears to be significant.
As shown in Figure 2A and C (previously Figure 2B and D), the amount of telomere-bound TRF1 is not significantly affected in cells stably expressing hTERT-HA, as compared to control cells infected with empty vector retroviruses. After normalization through total Alu input DNA and expression as fold increase over empty vector cells, the relative amount of telomeric DNA detected in anti-TRF1 ChIPs is 1 ± 0.044 in empty vector cells and 0.984 ± 0.19 (p= 0.9044; two-tailed Student's t-test) in hTERT-HA expressing cells.
The authors specifically state that UPF1 binds to active hTERT. This however is not clear from Figure 2 , so this statement should be weakened. We have carefully edited the text and suggested that UPF1 interacts with active telomerase only when discussing experiments involving TRAP assays, which specifically detect telomerase activity.
Why was no leading strand telomere phenotype observed in the TPP1 knockout?
To our knowledge, no telomeric CO-FISH assay has so far been performed in cells derived from TPP1 knockout mice. Nevertheless, a recent report from the Blasco laboratory (CNIO, Madrid) revealed the presence of fragile telomeres in mouse embryonic fibroblasts conditionally deleted for TPP1, although no information is available about the affected telomeric strand affected (Tejera et al. 2010, Dev. Cell 18: 775-789) . We have now referenced this published data and we speculate that the telomeric fragility observed upon TPP1 deletion might stem, at least in part, from compromised function of UPF1 at telomeres (Discussion, pages 17-18).
The single stranded telomere detection approaches in Figure 7 are experimentally weak and could simply be left out.
See response to point 3 of Referee #2. P values (calculated using a two-tailed Student's t-test) are now indicated in the quantifications shown in Figures 1C and 2C . In addition, we have performed anti-UPF1 ChIPs in HeLa cells synchronized at the G1/S transition with a single aphidicolin block and released synchronously into the cell cycle for 4 hours (corresponding to S phase) and 8 hours (corresponding to G2/M phase). The fraction of telomeric DNA immunoprecipitated with anti-UPF1 antibodies does not differ among the three samples (0, 4 and 8 hours). Therefore, UPF1 is present at telomeres at least during S and G2/M phases, further corroborating our suggestion that UPF1 sustains the replication of telomeric DNA. Whether UPF1 remains at telomeres during G1 still needs to be clarified. Nevertheless, we believe that this particular information is not relevant for the model discussed in the manuscript. The new data are presented in Figure 2A and C and in Supplementary Figure S1B and F. They are discussed on pages 7 (Results) and 17 (Discussion). Fig. 5 We now show a statistical analysis for the appearance of fragile telomeres on chromatids generated by leading-or lagging-strand semi-conservative DNA replication. As is the case for TFEs, also FTs occur predominantly at leading-strand telomeres. The results are presented in Figure 6D and E, and they are discussed in the text (Results, page 13; Discussion, pages 18-19).
The authors demonstrate nicely that shUPF1 increases telomere free ends and fragile telomeres in

In Fig. 7, the authors included ss signals from wells for quantitation. It is unclear why the authors included them. Since the control shEV also contain strong signals in wells, which it shouldn't, how do the authors know that the well signals are not from non-specific binding of probe to DNA? Many publications from various groups have shown that most if not all human telomere DNA is able to migrate into agarose gel and the signals from wells are very minimal. This raises question about whether the technique worked properly in the author's hands. In addition, statistical analysis should be conducted for fig. 7C.
We agree with the Referee that the results presented in Figure 8A and B (previously Figure 7A and B) are somewhat surprising. Indeed, we routinely perform telomere restriction fragment (TRF) analysis in the laboratory using genomic DNA from different human cell lines. HeLa-E1 are the only cells showing this striking accumulation of telomeric signal in the wells of the gel, possibly due to the dramatic increase in the length of their telomeres. For this reason and for the high reproducibility of these experiments, we strongly believe that the technique indeed worked properly in our hands. In addition, the telomeric signal in the wells is more sensitive to treatment with mung bean nuclease in cells depleted for UPF1 than in control cells ( Figure 8C , previously Figure 7C ). This observation further corroborates the notion that, at least in UPF1-depleted HeLa-E1 cells, the retention of telomeric DNA in the wells largely derives from accumulation of single-stranded telomeric DNA. We have now repeated the same experiments several times and we present a thorough statistical analysis of the data ( Figure 8B ). For the reasons discussed above and for the robustness of the presented statistical analysis, we are confident that the data are solid and truly reflect a telomeric defect associated with depletion of UPF1, likely involving exposure of telomeric single-stranded DNA.
Referee #3
1. The impact of caffeine on the association of UPF1 with telomerase activity is striking. Nonetheless, the authors should include an internal control for the telomere repeat addition protocol (TRAP), which will confirm equivalent PCR amplification efficiency. In Figures 2B and 3B , an extract titration (as in Fig. 3A We agree with the Referee that the effects exerted by caffeine and by the ATR shRNA on the TRAP activity detected in anti-UPF1 immunoprecipitates are compelling. We have now added a statistical analysis of these results ( Figure 4D ), further corroborating the solidity of these experiments. Given the high reproducibility of these experiments, we have not included an internal amplification control for our TRAPs at this stage. We clearly favor the hypothesis that chemical or shRNA-mediated inhibition of ATR negatively regulates the physical interaction between UPF1 and active telomerase. Nevertheless, we indeed cannot exclude that the lower amounts of TRAP activity detected in UPF1 immunoprecipitates from the ATR-inhibited samples might derive from an inhibition of telomerase activity or of the PCR, specifically in those samples. We have now acknowledged this point in the text (Results, page 11). We have also added a second dilution (0.1%) of input extract in the assay shown in Figure 3B (originally Figure 2B) . Together, both input dilutions now show that the telomerase activity measured in the anti-UPF1 immunoprecipitates lies within the linear range of the TRAP assay. The same also applies for the TRAP experiments shown in Figure 4A and B (originally Figure 3A and B) , where different dilutions of input extracts were already presented previously. Finally, we believe that the anti-UPF2 immunoprecipitation included in Figure 3B substitutes well for an 'irrelevant antibody' control, given the fact that UPF2 protein is not present in anti-hTERT immunoprecipitates ( Figure 3A) . We would like to highlight here that the molecular details and the functional significance of the interaction between UPF1 and telomerase are a major focus of ongoing research in our laboratory. We are currently setting up ad hoc experimental systems to better dissect the details of this interaction and we anticipate that this research will clarify at least some of the issues raised. We have now included quantifications of telomeric DNA immunoprecipitated using anti-UPF1 antibodies, after normalization to total input telomeric DNA, in the text (Results, page 8). These results indicate that telomere elongation increases the absolute amount but not the density of telomere-bound UPF1. In other words, the increase in telomere-bound UPF1, observed in cells with longer telomeres, derives from the fact that more substrate is available for direct or indirect binding of UPF1. We have clarified this issue in the text (Results, page 8).
The number of telomeric DNA repeats in cell lines that overexpress hTERT is greater than EV or hTERT-HA controls, and it is unclear whether the UPF1-telomere association is enriched when
3. The data in Figure 5 illustrates the biological significance of UPF1 ATPase activity in telomere replication and integrity in vivo, and the statistical analysis underscores these compelling effects. Figures 1D, 3D , 6B and 7B, e.g. Figure 5 ).
Please also include statistical analysis (p-values) for the data in
two-tailed student's t-test or one-way ANOVA. Wherever percentage values are mentioned in the text, please include S.E. or STD DEV and p-values for the relevant sample comparison. In Figure 4, although one representative experiment is shown, it would be helpful to mention how many times the experiments were replicated for each figure panel. Please include a section in the Methods to clarify how the ChIP data was normalized, and statistical methods to explain how p-values were calculated (including the Mann-Whitney tests in
We have now included statistical analyses for all quantifications presented in the major figures. For sake of clarity, we decided to calculate all p values using a two-tailed Student's t-test. Whenever percentages are indicated in the text, we have also included averages, standard deviations and p values. We have indicated the number of experimental replicates in the legends of Figures 3 and 5 (originally Figures 2 and 4) . Finally, we have explained how the ChIP data were analyzed and normalized and we have included a brief description of the utilized statistical analysis (p value calculation) in the appropriate sections of Materials and Methods. (Fig.  1D) Fig. 2C ).
In vivo, the association of UPF1 with telomeres was reduced in cells expressing hTERT-HA
We have discussed the possibility that the decreased levels of telomere-bound UPF1 measured in hTERT-HA-expressing cells might derive from a dominant negative effect exerted by mislocalized hTERT-HA on UPF1 association to telomeres (Results, pages 8-9). As already mentioned above, the molecular details and the functional significance of the interaction between UPF1 and telomerase are a major focus of ongoing research in our laboratory and we plan to address these different possibilities experimentally in the future.
5.
Minor grammatical editing and clarification would be beneficial, for example some terms such as "associated to only beads samples", "knocked-out", "properly running in the gel" and "wellassociated" could be replaced with more precise terminology. In some cases, the singular tense might be more appropriate (e.g. "dysfunctions", "settings") . In Methods, "%" should be followed by "w/v" or "v/v We have indicated which antibody was used for each of the two hTERT panels in the legend of Supplementary Figure S1 . We now explain that the band pointed out by the Referee (and now marked by an asterisk in the figure) likely derives from incomplete stripping of the membrane after probing with -hTERT antibody.
2nd Editorial Decision 05 July 2011
Thank you for submitting your revised manuscript for consideration by The EMBO Journal. It has now been assessed once more by one of the original referees (see comments below), who acknowledges that the majority of the initial concerns have been satisfactorily addressed and that the manuscript is now in principle suitable for EMBOJ publication. There remain a few minor issues to be taken care of -most notably concerning the revised Figure 8 : here referee 2 feels that it should either be improved/clarified, or left out of the final manuscript. It would be great if you could easily address the concerns with that figure, but I am not going to insist on further improvements of these data -as referee 1 already originally suggested to omit these data, I will leave it up to you to decide how to proceed with this figure.
In either case, please return your final minor revision back to us as soon as possible. After that, we should then be happy to proceed with the formal acceptance and publication of the paper! Yours sincerely, Editor The EMBO Journal _____ REFEREE REPORTS:
The authors have addressed most of the concerns and the manuscript has been considerably strengthened. However, the ssDNA measurement data in the new Fig 8 is still not convincing enough. Specifically, the authors showed that the amount of TTAGGG signal in "denatured" gel was reduced after MBN treatment and interpreted that this was due to ssDNA in shUPF1 sample was digested by MBN. This is not convincing because compared to total ds telomere DNA, the amount of ssDNA should be very low, even there's a 2 fold increase of ssDNA compared to shEV. If MBN removed considerable amount of signal in denatured gel, as shown in Fig 8C, it indicates that MBN nonspecifically digested some ds telomere DNA. A native gel with MBN treated sample and the same gel after denaturing should be shown. Nonetheless, Fig. 8A -C can be left out without affecting the general conclusion of this manuscript. However, if the authors choose to include the data, please address this concern in the revised manuscript. Also, ssDNA should be calculated as follows: telomere signal from native gel divided by telomere signal from denaturing gel. According to what is written in Fig 8B legend (page 37) , it seems that signal from wells in native gel was normalized to signal from the gel (tels) in denaturing gel. Because both DNA in the "wells" and "tels" contain telomere DNA, the authors should have used wells+tels native signal to normalize wells+tels denaturing signal. Please clarify. In addition, please include a section in Methods to clarify how normalization was done in Fig 8B, as it is unclear what the y axis is as the graph shows now.
Others:
On p17-18, the authors discussed quite extensively on the connection between TPP1 and UPF1. However, it is still controversial whether TPP1 deficiency induces fragile telomeres, as de Lange's and Blasco's groups reported different results. The authors need to be cautious when connecting the fragile telomere phenotype from UPF1 deficient cells with TPP1.
2nd Revision -authors' response 16 July 2011
We would like to thank you for giving us the possibility to submit a second revised version of our manuscript entitled 'Human UPF1 interacts with TPP1 and telomerase and sustains telomere leading-strand replication' (Manuscript EMBOJ-2011-77691) for publication in the EMBO Journal.
As explained in the following 'point-by-point response', we have now addressed the concerns of the Referee and we hope that the current version of our manuscript is suitable for publication in the EMBO Journal.
We thank you very much for your kind help, We have now removed the analysis of single stranded DNA accumulation in cells depleted for UPF1, originally shown in Figure 8 A-C. We have also changed the text accordingly. The current Figure 8 only shows the speculative model on UPF1 association and function at telomeres. We have removed the specific reference to the accumulation of fragile telomeres in mouse cells deficient for TPP1 and we now only refer to 'rare telomeric aberrations'.
